1. Home
  2. PCRX vs BH Comparison

PCRX vs BH Comparison

Compare PCRX & BH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$25.10

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Biglari Holdings Inc. Class B

BH

Biglari Holdings Inc. Class B

HOLD

Current Price

$297.03

Market Cap

971.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCRX
BH
Founded
2006
1934
Country
United States
United States
Employees
N/A
2359
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
971.1M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
PCRX
BH
Price
$25.10
$297.03
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$30.25
N/A
AVG Volume (30 Days)
398.4K
80.1K
Earning Date
04-30-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
107.44
N/A
EPS
0.16
N/A
Revenue
$541,533,000.00
N/A
Revenue This Year
$6.78
N/A
Revenue Next Year
$8.54
N/A
P/E Ratio
$158.81
$597.67
Revenue Growth
26.04
N/A
52 Week Low
$18.80
$225.70
52 Week High
$27.64
$483.60

Technical Indicators

Market Signals
Indicator
PCRX
BH
Relative Strength Index (RSI) 58.93 39.07
Support Level $20.56 $269.96
Resistance Level $25.23 $324.74
Average True Range (ATR) 0.88 13.75
MACD 0.09 -0.77
Stochastic Oscillator 65.79 16.23

Price Performance

Historical Comparison
PCRX
BH

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About BH Biglari Holdings Inc. Class B

Biglari Holdings Inc is a holding company that owns subsidiaries in a range of businesses. The company's reportable segments include Restaurant Operations, Insurance Operations, and Oil and Gas Operations. Its restaurant operations include Steak n Shake and Western Sizzlin. Its insurance operations include First Guard, Southern Pioneer, and Biglari Reinsurance. Oil and gas operations include Southern Oil and Abraxas Petroleum. The company also reports segment information for Maxim. The majority of revenue is derived from the Restaurant Operations Segment.

Share on Social Networks: